Filing Details

Accession Number:
0001209191-14-067718
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-10 18:30:07
Reporting Period:
2014-11-10
Filing Date:
2014-11-10
Accepted Time:
2014-11-10 18:30:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
949699 Pharmacyclics Inc PCYC Pharmaceutical Preparations (2834) 943148201
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1555168 B Richard Love C/O Pharmacyclics, Inc.
995 East Arques Avenue
Sunnyvale CA 94085
General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-10 1,500 $32.38 1,705 No 4 M Direct
Common Stock Disposition 2014-11-10 1,500 $133.87 205 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2014-11-10 1,500 $0.00 1,500 $32.38
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
64,000 2012-06-04 2022-06-04 No 4 M Direct
Footnotes
  1. The option shares vest 25% on each of April 11, 2013, April 11, 2014, April 11, 2015 and April 11, 2016, subject to satisfaction of certain performance criteria with respect to each vesting period. Such performance criteria is to be determined and approved by the Compensation Committee.